We use cookies on our websites to ensure the proper functioning of the website and to help provide the best user experience.
By continuing to use our site, you agree to the use of cookies. Learn more about cookies here.


Cisbio Bioassays and Orion Diagnostica Oy sign an agreement for steroid radioimmunoassays

On October 1, 2013 - Cisbio Bioassays and Orion Diagnostica Oy signed an agreement covering raw materials and related documentation for manufacturing of ultrasensitive Estradiol, Cortisol and Testosterone radioimmunoassays. Cisbio Bioassays plans to start the manufacturing and worldwide marketing based on these assets in 2014. Until then, these assays remain available from Orion Diagnostica Oy, under the brand name Spectria. “We are delighted that through this arrangement Orion Diagnostica Oy’s long term global customers for Spectria radioimmunoassay will have a possibility for continuation with products manufactured by our long term partner.” Jaakko Rissanen, President, Orion Diagnostica Oy concludes.